Four years ago today, we officially marked the opening of the Iovance Cell Therapy Center (iCTC) in Philadelphia as the first U.S. facility dedicated to manufacturing TIL cell therapies! Learn more about iCTC and cell therapy manufacturing: www.iovance.com/iovance-cell...

We're excited to share that we received our first marketing authorization outside the U.S. for our cell therapy in advanced melanoma. Learn more: ir.iovance.com/news-release...

We are honored to present the SITC Medal of Honor to Marc Theoret for his incredible partnership while at the FDA. This award recognizes his stewardship of innovative regulatory approaches to immuno-oncology drug development and approval. LEARN MORE: www.sitcancer.org/about/awards...

🫁 Lung cancer is the leading cause of cancer death worldwide. On #WorldLungCancerDay, we reaffirm our commitment to changing the way cancer is treated. 🔬 Learn about our ongoing lung cancer clinical trial: www.tilcelltherapy.com/clinical-tri... #LungCancerResearch

We're in for Chicago at #ASCO25! Visit us at Booth 14111 or check out our presentation or poster: ir.iovance.com/news-release...

Throughout the year and especially during #MelanomaAwarenessMonth, we are committed to following the science to drive innovation for patients. Check out @melanomaresearch.bsky.social's recent webinar on a clinical trial option: www.curemelanoma.org/blog/mra-mee...

5-yr results of our phase 2 study of lifileucel in advanced melanoma will be presented for the first time at #ASCO25. Learn more: ir.iovance.com/news-release...

Philly weekly roundup: Iovance Biotherapeutics expands; Jawnt-SpotHero partnership; Mayor’s budget address

At Iovance, we recognize and celebrate the pivotal role women play in advancing science and innovation. #womeninbiotech #womenshistorymonth #womeninSTEM

Today Iovance reported fourth quarter and full year 2024 financial results and corporate updates. We will host an audio webcast at 4:30 pm ET, join live or listen to the replay: ir.iovance.com/news-release...

Please join us in welcoming Dan Kirby to Iovance in the newly created role of Chief Commercial Officer: ir.iovance.com/news-release...

This Black History Month, we honor African American dermatologists who paved the way for skin health research. By supporting diverse voices in dermatology, we accelerate scientific discovery and improve outcomes for all melanoma patients. #BlackHistoryMonth #HealthEquality

Iovance is ready for an exciting 2025! We continue to expect significant growth in line with our full-year revenue guidance for 2024 and 2025. Check out our latest corporate presentation: ir.iovance.com/news-events/...

Dr. Raj Puri has been promoted to Chief Regulatory Officer at Iovance! Raj has been instrumental in our U.S. FDA approval and in advancing regulatory submissions in the EU, UK, Canada, Australia, and Switzerland. Congratulations Raj! ir.iovance.com/news-release...

Today at 12:40 pm ET, our COO Igor Bilinsky and SVP Medical Affairs Peter A. Prieto, MD will participate in a fireside chat at the Stifel 2024 Healthcare Conference. Register here for the live webcast or replay: ir.iovance.com/events/event...